At a glance
ClinicalIndex Comparison RecordN/ACompleted· 160 enrolled
Drug / intervention
ON101 Creamdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective Record-review Study in Patients Who Had Participated in the ON101CLCT02 Diabetic Foot Ulcer Trial
In Brief
An observational study evaluating ON101 Cream for Diabetic Foot Ulcer. Completed, enrolled 160 participants across 1 site.
Detailed Summary
The purpose of the study is to evaluate the medical cost of illness for DFUs on the patients who had used ON101 or Aquacel® in the ON101CLCT02 trial.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcer
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedNov 2021
Primary CompletionJan 2022
TodayJul 2026
First PostedNov 26, 2021
Enrollment StartOct 4, 2021
Primary CompletionJan 20, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.6 years ago
Interventions
ON101 Creamdrug
Not applicable in this retrospective study